baber/WOPTO huggingface dataset:
Patent NZ-213476-A (NZ)
Title: Pile type weatherstrip with lubricant filled channel barrier
Inventor: KESSLER MILTON
IPC: E06B7/22
Filed: 1985-09-16
Abstract: An improved pile-type, fin weatherstrip includes an elongated V- or U-shaped barrier fin bonded to a base strip and located between a pair of upstanding pile fiber arrays. The barrier fin is formed of thermoplastic film which is preferably smooth, but which may be roughened, dimpled or otherwise provided with a large number of pockets, or which may have a flocked surface. A lubricant grease is provided in the channel shaped cavity of the barrier fin, which lubricant is progressively dispensed in response to a wiping action type of movement which occurs when the barrier fin is compressed by the pile arrays during usage. The lubricant grease is exuded progressively over the useful life of the weatherstrip toward the free edges of the barrier fin located at or near the forward projecting face of the weatherstrip where such grease is dispensed in small amounts to decrease breakaway force, lower sliding friction and improved air infiltration characteristics. The barrier fin may be perforated so that lubricant grease is also forced into the fibers of the pile arrays where it will also work to the surface of the weatherstrip and improve the aforementioned properties.
Patent NZ-226223-A (NZ)
Title: Preparation of (2s,3as,7as)-2-carboxyperhydroindole, and use thereof in the preparation of dipeptides
Inventor: VINCENT MICHEL
IPC: C07D209/42
Filed: 1988-09-16
Abstract: Process for the industrial synthesis of (2S, 3 7aS)-2-carboxyperhydroindole by reduction of 2-carbox indole or of one of its esters to (R,S)-2-carboxyindo or of one of its esters which, after saponification, converted into the acid, the S isomer cf (R,S)-2-carboxyindoline being obtained by precipitation from the mixture of the two (R) and (S) isomers, in the presence of (+) methylbenzylamine, (S)-2-carboxyindoline being in its turn subjected to catalytic hydrogenation to give (2S, 3aS,7aS)-2-carboxyperhydroindole, after separation of (2S,3aR,7aR) isomer by crystallization. Application to the synthesis of carboxyalkyl d peptides capable of being employed in therapeutics.
Patent NZ-230644-A (NZ)
Title: Slit film yarn based on propylene polymer, and use as synthetic lawn
Inventor: DUEZ JEAN
IPC: C08F297/08
Filed: 1989-09-14
Abstract: Strips based on a propylene polymer and resistant to postfibrillation. The propylene polymer is a block copolymer of propylene and ethylene, composed of chain segments consisting of propylene homopolymer and chain segments consisting of a random copolymer of propylene and ethylene. 
<??>These strips are very suitable for the manufacture of synthetic lawn.
Patent NZ-234270-A (NZ)
Title: Muramyl dipeptide derivatives and pharmaceutical compositions
Inventor: CHEDID LOUIS
IPC: A61K38/03
Filed: 1990-06-27
Abstract: The 3-O-[N-acetylmuramyl-D-isoglutaminyl]-1,2-di-O-palmitoyl-sn-glycerol derivative of formula I <CHEM> wherein the carbon atom marked with an asterisk * has the R or, respectively, the S configuration, possesses interesting pharmacological, in particular immunomodulating properties. It is particularly indicated for use as an immunomodulant, as an adjuvant in vaccines and as a suppressing agent for IgE formation in e.g. type I allergies and atopical dermatitises. It is obtained by deprotection of a corresponding compound having one or more hydroxy groups(s) in protected form.
Patent NZ-234672-A (NZ)
Title: N-(1,2,3,4-tetrahydro-9-acridinyl)amide and carbamate derivatives and pharmaceutical compositions
Inventor: GRANGER COLIN
IPC: C07D219/10
Filed: 1990-07-27
Abstract: Novel prodrugs or depot derivatives of 1,2,3,4-tetrahydro-9-acridinamine of formula I <CHEM> are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as analgesic agents for the treatment of pain, as sleep aids and as agents for treating the symptoms of senile dementia, Alzheimer's disease, Huntington's chorea, tardive dyskinesia, hyperkinesia, mania, or similar conditions of cerebral insufficiency characterized by decreased cerebral acetylcholine production or release.
Patent NZ-237763-A (NZ)
Title: Powdered drug inhalor:doses poured into a collection chamber
Inventor: CHIESI PAOLO
IPC: A61M13/00
Filed: 1991-04-09
Abstract: This invention relates to a new inhaler for the local administration of powdered drugs to the respiratory tract. The apparatus consists of a nozzle (1) and a main body (2) which itself defines a storage chamber (8) for the medicinal substance, a dosing means (14,17) which supplies precisely measured doses of the drug and a dispensing system (18,19) which pours the dose of the drug delivered into a collecting chamber (24). The cavity (4) of the nozzle (1) communicates with the collecting chamber (24) through a central channel (6) designed to reduce air flow resistance as much as possible. Lateral holes (23) provided in the body (2) of the inhaler allow for the passage of air from the outside. Upon inhalation, a negative pressure is created in the chamber (24) in which the dose of powder delivered is collected, drawing an air inflow from the outside. The air flow is mixed with the medicinal substance particles and through the central channel (6), enters the cavity (4) of the nozzle (1) from where it is directly inhaled. <IMAGE>
Patent NZ-244807-A (NZ)
Title: Ccompositions containing peptides having at least part of the sequence of human myelin protein
Inventor: WARREN KENNETH G
IPC: C07K14/47
Filed: 1992-10-20
Abstract: Human basic myelin protein (h-MBP) has a molecular weight of 18.5 KD and contains 170 amino acid residues. Synthetic peptides ranging in length from 8 to 25 residues and covering the entire length of the protein have been produced. Antibodies to h-MBP (anti-MBP) were found to be neutralized by the synthetic peptides, which span the h-MBP from about amino acid residue (61) to about amino acid residue (106). The synthetic peptides, which cover both the amino (about residues 1 to 63) and carboxy (about residues 117 to 162) terminals of h-MBP did not neutralize purified anti-MBP. Accordingly, intrathecal administration of selected synthetic MBP peptides may be used as a treatment for Multiple Sclerosis by neutralizing anti-MBP.
Patent NZ-253963-A (NZ)
Title: Nucleic acid molecule capable of blocking or interfering with viral replication and its use in transforming plant and animal life forms
Inventor: ATKINS DAVID G
IPC: C12N15/09
Filed: 1993-06-29
Abstract: The invention consists of a non-naturally occurring nucleic acid molecule capable of blocking or interfering with a replicative intermediate of a virus, a virusoid, or a viroid. The nucleic acid molecule may contain a ribozyme or a plurality of ribozymes. Alternatively, the nucleic acid molecule may be an antisense nucleic acid molecule. The ribozyme may be a hairpin ribozyme, a hammerhead ribozyme, an RNAase P ribozyme, a minizyme, or other catalytic RNA molecule. The virus may be an animal, a mammalian, a plant, a fungal, a protozoan, a yeast, a bacterial virus, or a human virus. The nucleic acid molecule may be expressed in the cell or it may be preformed and administered (ex vivo). The present invention contemplates methods of controlling infection of a pathogenic infectious agent in a plant or animal.
Patent NZ-272284-A (NZ)
Title: Mono-and multilayer films comprising a layer which is a sealing layer or a seal-assist layer of a blend of polyethylene or ethylene-alpha-olefin copolymer and elastomer, plastomer or carboxyl-modified polyethylene
Inventor: KENNEDY THOMAS DUANE
IPC: B65D77/18
Filed: 1995-06-06
Abstract: Films containing a sealant layer composition comprising:   (1) polyethylene homopolymer, ethylene/ alpha -olefin copolymer, ethylene vinyl acetate copolymer, and/or ethylene/acrylate copolymer; and (2) elastomer, plastomer, ionomer, and/or carboxyl-modified polyethylene; when sealed to another outer film layer comprising ionomer, ethylene/acid copolymer, ethylene/vinyl acetate copolymer and/or ethylene/acrylate copolymer provide a seal having enhanced seal strength.
Patent NZ-286587-A (NZ)
Title: Model railway track: track sections have interfitting extensions and recesses at their ends
Inventor: GRUBB LAWRENCE B
IPC: A63H19/30
Filed: 1996-05-15
Abstract: The present invention is directed to track locking systems for model railroads of the type in which separate sections of track are removably connected to form a desired closed pattern over which a model train will travel. The track sections include electrically conductive rails for supporting and guiding the model train thereon, and for providing electrical energy from a source for driving the train. Individual track bed sections connected to each other are joined at two laterally offset positions to enhance the stability of the sections removably locked together. The locking elements on the respective track sections joined together are oriented at substantially right angles to the direction of the rails to further enhance the stability and integrity of the joined track sections. A secure connection between locked track sections assures a positive engagement between electrical connectors to provide a completed electrical circuit when the track sections are joined in the desired closed pattern. <IMAGE>
Patent NZ-290127-A (NZ)
Title: Dinucleoside-5',5'-p1,p2-pyrophosphates; medicaments for treating tumours and viral infections
Inventor: DE FLORA ANTONIO
IPC: A61K9/00
Filed: 1995-07-10
Abstract: 5',5'-Pyrophosphates of non-naturally occurring nucleosides selected from thymine-3'-azido-2',3'-dideoxy-D-riboside, 5-fluorouracil-2'-deoxy-D-riboside, uracil-3'-azido-2',3'-dideoxy-D-riboside, guanine-2',3'-dideoxy-D-riboside, hypoxanthing-2',3'-dideoxy-D-riboside, cytosine-2',3'-dideoxy-D-riboside, and adenine-2',3'-dideoxy-D-riboside, are described as well as their manufacture and use as therapeutical pharmaceutical compositions or as pro-drugs encapsulated into biological carriers, e.g., transformed erythrocytes, for targeting to specific cell population responsible of the development of the pathological disorders.
Patent NZ-310852-A (NZ)
Title: use of melatonin agonists such as indole derivatives for treating benign prostatic hyperplasia
Inventor: CLARKE DAVID O
IPC: A61K31/40
Filed: 1996-06-12
Abstract: Melatonin agonists are used in the preparation of a medicament for treating benign prostatic hyperlasia in a mammal. The preferred melatonin agonist is N-[2-(substituted-3-indolyl)ethyl]amide such as N-[2-methyl-2-(5-methoxy-6-chloroindol-3-yl)ethyl]acetamide.
Patent NZ-330720-A (NZ)
Title: Wheelchair with a front wheel support, wheelchair with an adjustably inclined seat, wheelchair with variably inclined rear wheel axles, seat
Inventor: KUESCHALL RAINER
IPC: A61G5/12
Filed: 1999-06-14
Abstract: wheelchair 10 comprises a front wheel support 12.1 which is at least horizontal and has a fastening device 26,28,30 - not labelled, for a front wheel assembly 24 having two lateral longitudinal supports 12.3 with two inclined supports 12.2 which connect front wheel support 12.1 with the front ends of longitudinal supports 12.3.  An axle tube 14 connects two rear wheels 18 of a pair of wheels.  Front wheel support 12.1 is a transverse support and forms together with inclined supports 12.2 and longitudinal supports 12.3 adjoining them, a three-dimensional U-like integral support 12.  The rear ends of longitudinal supports 12.3 are connected with axle tube 14.
Patent NZ-331008-A (NZ)
Title: Surface modification of medical implants
Inventor: LEE DOSUK D
IPC: C23C8/36
Filed: 1997-01-22
Abstract: he electromagnetic behaviour of a body surrounded by a spatial region is simulated using a finite element method by a digital computer.  The method includes the following steps: a)	Subdividing at least the spatial region into a pattern or mesh of infinite elements, the pattern being stored in the memory.  This involves constructing a closed bounding surface around the body so that at least part of the spatial region, known as the external region, lies outside the bounding surface.  Each infinite element is bounded by a base, at least three side faces and an outer face, each base lies on the bounding surface and the outer face is at an infinite radius. b)	For each element of the pattern, computing a set of element matrix coefficients which are stored in memory. c)	All the element matrix coefficients are assembled into a system matrix which is also stored in memory. d)	The system matrix equation is solved to create a description of the values assumed within the mesh by one or more electromagnetic field variables, these variables include at least one scalar electromagnetic potential, and storing the description. Within the external region,  the one or more electromagnetic field variables include at least one scalar electromagnetic potential that has a Debye potential.  The step of computing element matrix coefficients is carried out such that the Sommerfeld radiation condition is satisfied, and also includes applying the Helmholtz equation to an approximation of a multipole expansion of an electromagnetic field variable.
Patent NZ-332417-A (NZ)
Title: Combination front receptacle and can handling apparatus for front loading refuse collection vehicle
Inventor: SHIRVANIAN KOSTI
IPC: B65F3/04
Filed: 1997-04-09
Abstract: A combination front receptacle for use with a front-loading type refuse vehicle (10) in the collection of refuse. The combination front receptacle is supported on the front forks (16) of the large dump arms (14) on the refuse collection vehicle and includes a front receptacle (32) and a refuse can handling assembly (42). The refuse can handling assembly includes a trolley extension (44) for moving laterally along the front of the front receptacle, a lifting arm (46), pivoting on the trolley extension, and gripping fingers (48) operatively connected to the lifting arm, for gripping a refuse can (38) and dumping it into the front receptacle. The front receptacle has an open top and is sufficiently large to allow the dumping of a number of refuse cans prior to requiring emptying into the main hopper (18) of the refuse collection vehicle.
Patent NZ-337464-A (NZ)
Title: Vulcanized innerliner and method of utilizing the same for pneumatic tires
Inventor: VANNAN FREDERICK FORBES
IPC: B60C/
Filed: 1997-03-25
Abstract: An original or retreaded tire is manufactured with a vulcanised, splice-free, elastomeric innerliner that is molded into the tire carcass and that has a cylindrical or toroidal shape and is formed from a sole curable rubber based material.
Patent NZ-338082-A (NZ)
Title: Metalloproteinase and Tumor Necrosis Factor-alpha convertase inhibitors, pharmaceutical compositions and their use in treating disease mediated by metalloproteinase activity.
Inventor: BLENDER STEVEN L
IPC: A61K31/18
Filed: 1998-03-31
Abstract: Compounds of formula (I), wherein: Y is O or S, Ar is an aryl group or a heteroaryl group, R is H, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, or -C(O)R1, wherein R1 is hydrogen, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, or NR2R3 wherein R2 and R3 independently are hydrogen, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, or a heteroaryl group, X is -NH-OH or -OH Also disclosed are the pharmaceutically acceptable prodrugs, salts and solvates of these compounds, as is the inhibition of metalloproteinase activity by administering a compound of the formula (I).  By inhibiting the activity of metalloproteinases, compounds of formula (I) have been found to be effective in treating tumor growth, invasion and metastasis, osteoarthritis, rheumatoid arthritis osteoporosis, periodontitis, gingivitus, chronic dermal wounds, corneal ulceration, degenerative skin disorders, multiple sclerosis, stroke or as further defined in the specification.
Patent NZ-501762-A (NZ)
Title: Satiety product comprising triglyceride oils and an emulsifier
Inventor: HERSLOF BENGT
IPC: A23L33/20
Filed: 1998-07-06
Abstract: A food composition capable of giving a prolonged feeling of satiety, comprising an oil-in-water emulsion of triglyceride oils having a solid fat content at ambient to body temperature with a lecithin or galactolipid based emulsifier in an aqueous solution.  The triglyceride oils are selected from palm oil, cocoa butter and other confectionary fats.
Patent NZ-504748-A (NZ)
Title: A building panel with core being typically lightweight and compressible, and surface cladding of resin and textile mesh
Inventor: LEE JOHN BARTHOLOMEW
IPC: E04C2/296
Filed: 1998-08-11
Abstract: A building panel (10) is disclosed including a core body (11) containing a compressible solid, and cladding layer (12), on at least one outer surface of the core body, and wherein the building panel is preferably foldable. Preferably, the core is a polymer foam, and the cladding layer is substantially more rigid than the core body for imparting strength thereto. The fold may be provided by cutting the cladding layer from what will become the inside surface of a fold, and removing sufficient material from the core body to permit the panel to be folded. The cladding layer includes a textile of a woven or non-woven mesh (16) with a resin component (17) in the form of a settable liquid applied to, and set into the interstices of the textile with the resin component substantially encapsulating the textile component.
Patent NZ-505070-A (NZ)
Title: An in vitro method for inhibiting Neisseria meningitidis bacteria of serogroups A, B, C and W135 using BPI
Inventor: GIROIR BRETT P
IPC: C12N15/09
Filed: 1997-05-09
Abstract: An in vitro method of inhibiting the growth and/or survival of bacteria selected from the group consisting of serogroups A, B, C and W135 of the gram-negative bacteria Neisseria meningitidis, the method comprising the step of contacting the bacteria with an effective amount of a bactericidal/permeability-increasing (BPI) protein product. Also disclosed is the use of a BPI protein product in the preparation of a medicament for inhibiting the growth and/or survival of bacteria selected from the group consisting of serogroups A, B, C and W135 of the gram-negative bacteria Neisseria meningitides. (62) Divided out of 332720
Patent NZ-515411-A (NZ)
Title: Identification of analytes by their two dimensional resolution via adsorption under two selectivity conditions
Inventor: HUTCHENS T WILLIAM
IPC: H01J49/04
Filed: 2001-11-12
Abstract: A method for detecting at least one diagnostic marker or a plurality of diagnostic markers of a disease such as cancer, heart disease, autoimmune disease, viral infection, Alzheimer's disease or diabetes, comprising the steps of: a) providing a substrate for use in desorption spectrometry that comprises at least one addressable location, each addressable location comprising an absorbent attached to the substrate wherein the adsorbent resolves at least one of the diagnostic markers under an elution condition; b) contacting the adsorbent with a biological sample ouch as tissue, blood, urine, stool, lymph, cerebrospinal fluid or interarticular fluid from a subject; c) washing the adsorbent under the elution condition to allow retention of the diagnostic marker or markers: and d) detecting the retained diagnostic marker or markers by desorption spectrometry.
Patent NZ-526327-A (NZ)
Title: Apparatus for detecting metal objects being put into a trash can where the antenna encircles the trash can opening
Inventor: COTTER JAMES E
IPC: G01V3/10
Filed: 2003-06-06
Abstract: A detector (100) for finding metal objects being disposed in garbage includes a driving coil, a receiving coil, and a voltage detector. The driving coil encircles an opening formed in a ring-like lid for the trashcan. The controller connects to the driving coil and oscillates a driving current in the driving coil. A receiving coil is disposed parallel to the driving coil and has a current induced therein from the driving current in the driving coil. The voltage detector connects to the coil and detects changes in voltage of the inducted current when a metal object passes through the driving coil and the receiving coil. The coils can be constructed from a flat ribbon coil (124) containing a plurality of parallel wires. The flat ribbon coil (124) can be supported under a trashcan lid (102) by a support.
Patent NZ-526531-A (NZ)
Title: Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
Inventor: CHAMBERS ROBERT JAMES
IPC: C07D405/12
Filed: 2001-12-24
Abstract: Compounds of the formula (1.0.0) that are suitable for use as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructive pulmonary disease are disclosed, wherein j is 1; k is 0 or 1; m is 1, 2, or 3; n is 1 or 2; W1 and W2 are -O-; Y is =C(R1a)- where R1a is -H, -F,-Cl, -CF3, -OCH3 or -(C2-C4) alkynyl; RA and RB are -H, -CF3 or -(C1-C4) alkyl; RC and RD are the same as RA and RB except that one of them must be -H; R3 is -H; J1 is phenyl; and R1, R2, R4, R5 and R6, D, and J2 are as defined in the specification.
Patent NZ-526697-A (NZ)
Title: Therapeutic heterocyclic compounds
Inventor: CHAPDELAINE MARC
IPC: C07D405/14
Filed: 2002-01-15
Abstract: Heterocyclic compounds of formula (I) are disclosed. These compounds are useful in the treatment of depression, generalized anxiety, eating disorders, dementia, panic disorder, sleep disorders, gastrointestinal disorders, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.
Patent NZ-526976-A (NZ)
Title: Pharmaceutical composition having reduced tendency for drug crystallization
Inventor: GAO PING
IPC: A61K31/365
Filed: 2002-01-15
Abstract: An orally deliverable pharmaceutical composition comprising: (a) a selective cyclooxygenase-2 inhibitory drug compound of low water solubility having formula (I); (b) a pharmaceutically acceptable solvent liquid selected from glycols and glycol ethers; and (c) a turbidity-decreasing polymer; wherein at least a substantial portion of the drug is in dissolved or solubilized form in the solvent liquid and wherein the polymer is present in an amount sufficient to substantially inhibit crystallization and/or precipitation of the drug in simulated gastric fluid; and the use of the composition in the manufacture of a medicament for treating a medical condition or disorder where treatment with a cyclooxygenase-2 inhibitor is indicated.
Patent NZ-528950-A (NZ)
Title: A mine roof support mesh
Inventor: MCGREGOR GRAEME STUART
IPC: E21D11/14
Filed: 2003-10-15
Abstract: A mine roof support mesh for supporting an area of a mine is disclosed. The mesh includes a first layer of parallel line wires (5) and a second layer of parallel cross wires (7) that are transverse to the line wires and are welded together at the intersection of the wires. The line wires include line wires (5a, 5b) that have a diameter that is larger than the majority of the other line wires of the mesh and are positioned towards one side of the mesh and define a bolting section (13) of the mesh. The line wires also include one or more than one other larger diameter line wires (5c) positioned towards the other side of the mesh.
Patent NZ-529190-A (NZ)
Title: Device for the treatment of tumours
Inventor: SCHONFELD ANDREAS
IPC: A61N1/20
Filed: 2002-03-30
Abstract: In apparatus for the treatment of tumors, comprising at least one generator having a power source, and at least two electrode needles for conducting current into, or out of, a tumor, a control arrangement is provided for limiting the current flowing through each electrode to a maximum value.